Cucurbit[7]uril as a Broad-Spectrum Antiviral Agent against Diverse RNA Viruses

Virol Sin. 2021 Oct;36(5):1165-1176. doi: 10.1007/s12250-021-00404-9. Epub 2021 May 26.

Abstract

The emergence and re-emergence of RNA virus outbreaks highlight the urgent need for the development of broad-spectrum antivirals. Polyamines are positively-charged small molecules required for the infectivity of a wide range of RNA viruses, therefore may become good antiviral targets. Cucurbit[7]uril (CB[7]), a synthetic macrocyclic molecule, which can bind with amine-based organic compounds with high affinity, has been shown to regulate bioactive molecules through competitive binding. In this study, we tested the antiviral activity of CB[7] against diverse RNA viruses, including a panel of enteroviruses (i.e. human enterovirus A71, coxsackievirus A16, coxsackievirus B3, and echovirus 11), some flaviviruses (i.e. dengue virus and Zika virus), and an alphavirus representative Semliki forest virus. CB[7] can inhibit virus replications in a variety of cell lines, and its mechanism of action is through the competitive binding with polyamines. Our findings not only for the first time provide evidence that CB[7] can be a promising broad-spectrum antiviral agent, but more importantly, offer a novel therapeutic strategy to fight against RNA viruses by supramolecular sequestration of polyamines.

Keywords: Broad-spectrum antiviral activity; Cucurbit[7] (CB[7]); RNA viruses.

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Bridged-Ring Compounds
  • Humans
  • Imidazoles
  • RNA Viruses*
  • Virus Replication
  • Zika Virus Infection* / drug therapy
  • Zika Virus*

Substances

  • Antiviral Agents
  • Bridged-Ring Compounds
  • Imidazoles
  • cucurbit(7)uril